Page 36 - தகவல்கள் பாதுகாப்பு கண்காணிப்பு பலகை News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RedHill announces positive DSMB futility review for P 2/3 COVID-19 study of opaganib

Credit: RedHill Biopharma Opaganib targets a human cell component involved in viral replication and is therefore expected to be effective against emerging viral variants with mutations in the spike protein Preliminary data from the non-powered U.S. Phase 2 study of opaganib demonstrated safety and positive efficacy data across key primary and secondary endpoints TEL AVIV, Israel and RALEIGH, NC, January 29, 2021, RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients.

Bryan gibbsRedhill biopharmaAdi frishMarkl levittOpaganib yelivaUs department of defenseUs national institute of healthCompany phaseWorld health organizationApogee biotechnology corpRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programCorporate business developmentOffice of orphan products development

Conspiracy theories on Covid-19 vaccine can be as deadly as virus itself

Conspiracy theories on Covid-19 vaccine can be as deadly as virus itself By Opinion Share The announcement by Health Minister Dr Zweli Mkhize on Wednesday night in a webinar that the first tranche of the vaccine doses will arrive in South Africa on 1 February, was long-awaited and welcomed by South Africans. With phase 1 of the rollout plan, government will initially prioritise healthcare workers on the frontline of the fight against the coronavirus and, as more vaccine doses become available, embark on full vaccination campaigns aimed at other high risk groups and ultimately, the general public. President Cyril Ramaphosa has said the vaccine rollout will be the most ambitious programme in our countryâs history. So, the last thing the world needs at the moment is fake news peddlers trying to convince people they shouldnât get the vaccine. This is particularly true as we face an infodemic of misinformation and fake news packaged as truth and evidence based. The conspira

United kingdomSouth africaSouth africansBill gatesCyril ramaphosaEuropean medicines agencyDrug administrationAfrican health products regulatory authorityWorld economic forumRegulatory agencyHealth minister dr zweli mkhizeSpanish fluData safety monitoring boardInstitutional ethicsUnited kingdom medicinesஒன்றுபட்டது கிஂக்டம்

RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib

Share this article Share this article TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ RedHill Biopharma Ltd. (Nasdaq: RDHL) ( RedHill or the Company ), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the global Phase 2/3 study of opaganib [1] in patients with severe COVID-19, unanimously recommended to continue the study following a pre-scheduled futility review of unblinded efficacy data from the first 135 patients treated in the study and safety data from the first 175 patients. Opaganib is a novel, orally-administered sphingosine kinase-2 (SK2) inhibitor with demonstrated antiviral, anti-inflammatory, and anti-thrombotic activity. The positive and unanimous DSMB recommendation is a significant milestone in the progress of our development program for COVID-19 disease. Taken together with the positive results from the Phase 2 study, this unanimous DSMB recommendation to continue the global P

Bryan gibbsRedhill biopharmaAdi frishMarkl levittOpaganib yelivaUs department of defenseUs national institute of healthCompany phaseWorld health organizationApogee biotechnology corpRedhill biopharma ltdExchange commissionCompany annual report on formCompany expanded access programCorporate business developmentOffice of orphan products development

The need for a global COVID-19 maternal immunisation research plan

The need for a global COVID-19 maternal immunisation research plan
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South africaUnited statesMarko geber gettyMaternal immunization working groupWorld health organizationElsevier ltdCoalition for epidemic preparedness innovationsHealth organizationView largeSouth americaFam plannSafety platformEpidemic preparedness innovationsData safety monitoring boardImmunization workingஒன்றுபட்டது மாநிலங்களில்

Coronavirus Outbreak Timeline Fast Facts

Coronavirus Outbreak Timeline Fast Facts
kvia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kvia.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkUnited kingdomWhite houseDistrict of columbiaYing yongSan franciscoNew zealandNew jerseyWorld health organizationAl qahirahSouth koreaDonald trumpThomas bachMike penceinAnthony fauci